Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | CBD Science Group |
Description | Helping Cancer Patients with Chronic Pain Creating Ethical Shareholder CBD Science is pioneering the development of cannabis-based treatments for cancer pain. CBD Science Group PLC is working with world-class physicians, and Britain’s official regulatory authorities to allow the legal availability of new pain |
Keywords | N/A |
WebSite | cbdsciencegroup.co.uk |
Host IP | 109.106.240.17 |
Location | Serbia |
Site | Rank |
US$457,513
Last updated: 2022-06-22 17:53:47
cbdsciencegroup.co.uk has Semrush global rank of 23,134,448. cbdsciencegroup.co.uk has an estimated worth of US$ 457,513, based on its estimated Ads revenue. cbdsciencegroup.co.uk receives approximately 52,790 unique visitors each day. Its web server is located in Serbia, with IP address 109.106.240.17. According to SiteAdvisor, cbdsciencegroup.co.uk is safe to visit. |
Purchase/Sale Value | US$457,513 |
Daily Ads Revenue | US$423 |
Monthly Ads Revenue | US$12,670 |
Yearly Ads Revenue | US$152,035 |
Daily Unique Visitors | 3,520 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cbdsciencegroup.co.uk. | A | 14398 | IP: 109.106.240.17 |
cbdsciencegroup.co.uk. | NS | 86400 | NS Record: ns1.dns-parking.com. |
cbdsciencegroup.co.uk. | NS | 86400 | NS Record: ns2.dns-parking.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 5 mx1.hostinger.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 10 aspmx2.googlemail.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 10 mx2.hostinger.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
cbdsciencegroup.co.uk. | MX | 3600 | MX Record: 10 aspmx3.googlemail.com. |
cbdsciencegroup.co.uk. | TXT | 3600 | TXT Record: google-site-verification=l8lUg57-Tz90QXZP337rg_dxxr4Tpa3Gak_b-p6a5X4 |
cbdsciencegroup.co.uk. | TXT | 3600 | TXT Record: v=spf1 include:_spf.mail.hostinger.com ~all |
cbdsciencegroup.co.uk. | TXT | 3600 | TXT Record: google-site-verification=koPb3W9zsm4qkNt8E__RQdzpj4FHqkkm2s-qZiywr04 |
Helping Cancer Patients with Chronic Pain Creating Ethical Shareholder Value Home About Us Business Strategy Key Stakeholders Clinical Study Real World Evidence Our Clinical Partners Advisory Board/Committee Invest News & Research Contact Us Menu Home About Us Business Strategy Key Stakeholders Clinical Study Real World Evidence Our Clinical Partners Advisory Board/Committee Invest News & Research Contact Us Our Mission Join us & help patients suffering today. “We will research, develop and make available commercially effective and affordable plant-based cannabinoid medicines specifically for treating patients suffering from cancer related pain in the UK.” Dr. Michael Raymont – Chairman CBD Science Group PLC About us Research Investors Media Contact Real World Evidence Multidimensional Evidence Generation and FDA Regulatory Decision Making Real World Evidence Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician Real World Evidence The Expanding Role of |
HTTP/1.1 301 Moved Permanently Connection: Keep-Alive Keep-Alive: timeout=5, max=100 date: Sun, 24 Oct 2021 03:28:33 GMT server: LiteSpeed location: https://cbdsciencegroup.co.uk/ content-security-policy: upgrade-insecure-requests HTTP/2 200 x-powered-by: PHP/7.4.13 content-type: text/html; charset=UTF-8 date: Sun, 24 Oct 2021 03:28:35 GMT server: LiteSpeed content-security-policy: upgrade-insecure-requests alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46" |